Treating mucosal lesions with hyaluronan delivered from an adhering troche
AssigneeOraHealth Corp.
InventorJeffrey Haley
Life of this patent
Estimating the term…
Abstract
A troche comprising at least 5 mg hyaluronan, wherein the troche is adherent, and wherein hyaluronan is released from the troche, is used to treat mucositis, including stomatitis, vestibulitis, aphthous ulcerations, lichen planus and Behcet's syndrome. A method for treating or preventing mucositis in a patient is provided, comprising applying to a mucosal surface or a tooth or orthodontic brace of a patient in need thereof an adhering troche comprising at least 5 mg hyaluronan.
Claims14
A troche comprising at least 5 mg hyaluronan, wherein the troche is adherent, and wherein hyaluronan is released from the troche, thereby treating mucositis.
A method for treating or preventing mucositis in a patient comprising:
- applying an adhering troche comprising at least 5 mg hyaluronan to a mucosal surface or a tooth or orthodontic brace of a patient in need thereof.
Dependencies are inferred from the claim text.